Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Esperion Theraptc
(NQ:
ESPR
)
2.360
-0.230 (-8.88%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Esperion Theraptc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Esperion Announces Submission of Application for Expanded Indication with the European Medicines Agency (EMA) for NILEMDO® (bempedoic acid) Tablet and NUSTENDI® (bempedoic acid and ezetimibe) Tablet
June 28, 2023
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Analyst Expectations for Esperion Therapeutics's Future
June 26, 2023
Via
Benzinga
Esperion Presents Results from CLEAR Outcomes Primary Prevention Analysis at 83rd American Diabetes Association Scientific Sessions
June 24, 2023
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Esperion Presents Results from New Analysis on Cardiovascular Benefits with Bempedoic Acid Treatment at ENDO 2023
June 15, 2023
Cardiovascular risk reduction with bempedoic acid shown via the Cholesterol Treatment Trialists’ (CTT) Major Vascular Event endpoint is comparable to the normalized risk reduction with statins observed...
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Analyst Ratings for Esperion Therapeutics
June 01, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2023
June 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 15, 2023
Via
Benzinga
Verastem To Rally Around 287%? Here Are 10 Other Analyst Forecasts For Thursday
June 15, 2023
Piper Sandler boosted the price target for Accenture plc (NYSE: ACN) from $250 to $316. Piper Sandler analyst Arvind Ramnani upgraded the stock from Underweight to Neutral. Accenture shares rose 1.1%...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
June 15, 2023
It's time to start breaking down the biggest pre-market stock movers for Thursday as we get ready for another busy day of trading!
Via
InvestorPlace
Esperion to Present New Key Science at the American Diabetes Association’s 83rd Scientific Sessions 2023
June 08, 2023
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Esperion to Present Additional Analyses from the Landmark CLEAR Outcomes Study at ENDO 2023
June 05, 2023
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Esperion Announces Submission of Supplemental New Drug Applications to U.S. FDA for NEXLETOL® (bempedoic acid) Tablet and NEXLIZET® (bempedoic acid and ezetimibe) Tablet
June 01, 2023
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Esperion Announces Adjournment of 2023 Annual Meeting of Stockholders
May 25, 2023
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Esperion to Participate in Jefferies Healthcare Conference
May 24, 2023
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 12, 2023
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Esperion Therapeutics And 2 Other Stocks Under $3 Insiders Are Aggressively Buying
May 11, 2023
The Dow Jones closed slightly lower on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in...
Via
Benzinga
Esperion Reports First Quarter 2023 Financial Results
May 09, 2023
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Esperion Retains Gibson Dunn to Secure $300 Million Payment From DSE; Will Announce First Quarter Financial Results Tuesday, May 9
May 04, 2023
– Gibson Dunn Files Amended Complaint with Powerful New Evidence –
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Esperion to Participate in JMP Securities Life Sciences Conference
May 01, 2023
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Esperion to Participate in Bank of America Securities 2023 Health Care Conference
April 27, 2023
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Top 5 Health Care Stocks That Are Preparing To Pump In Q2
April 26, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Esperion to Report First Quarter 2023 Financial Results May 9, 2023
April 25, 2023
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Esperion Announces Co-Promotion Agreement With Currax Pharmaceuticals LLC
April 19, 2023
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
7 Very Undervalued Penny Stocks to Buy in April 2023
April 06, 2023
Undervalued penny stocks present investors who are very bullish on the near-term future with a high-risk, high-reward option.
Via
InvestorPlace
Why SeaChange International Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
April 06, 2023
Gainers
Via
Benzinga
Esperion to Participate in Needham 22nd Annual Virtual Healthcare Conference
April 03, 2023
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Top 5 Health Care Stocks That Preparing To Pump This Quarter
March 29, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Esperion Announces Closing of $56.7 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
March 22, 2023
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 20, 2023
Via
Benzinga
Esperion Announces $56.7 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
March 20, 2023
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.